Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | IMMUNOVIA AB: Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas-Inherited Gastrointestinal Cancers | 3 | Cision News | ||
12.11. | Immunovia AB: Invitation to Immunovia's Q3 presentation | 105 | PR Newswire | LUND, Sweden, Nov. 12, 2024 /PRNewswire/ -- Immunovia will publish its third quarter 2024 results on November 27, 2024 at 8:30 am CET. Analysts, investors and media are invited to a webcast... ► Artikel lesen | |
IMMUNOVIA Aktie jetzt für 0€ handeln | |||||
07.11. | Immunovia AB: Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortium | 209 | PR Newswire | SAN DIEGO, Nov. 7, 2024 /PRNewswire/ -- Immunovia (NASDAQ STOCKHOLM: IMMNOV), the pancreatic cancer diagnostics company, will present an update on its next-generation test at the annual... ► Artikel lesen | |
07.10. | Immunovia AB: Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer | 306 | PR Newswire | LUND, Sweden, Oct. 7, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the company has acquired all blood samples... ► Artikel lesen | |
02.10. | Immunovia AB: Immunovia completes analytical validation of its next-generation pancreatic cancer test | 248 | PR Newswire | LUND, Sweden, Oct. 2, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the company has completed the analytical validation... ► Artikel lesen | |
30.09. | Change in number of shares and votes in Immunovia AB (publ) | 200 | PR Newswire | LUND, Sweden, Sept. 30, 2024 /PRNewswire/ -- During September 2024, the registered number of shares and votes in Immunovia AB (publ) ("Immunovia") has increased due to the rights issue of... ► Artikel lesen | |
27.09. | Nasdaq Stockholm AB: New equity right for trading, Immunovia AB (publ) | 229 | GlobeNewswire | At the request of Immunovia AB (publ), Immunovia AB equity rights TO 2 and TO 3
will be traded on Nasdaq Stockholm as from September 30, 2024.
IMMNOV TO 2
Security name: Immunovia AB TO 2
---------------------------------
Short... ► Artikel lesen | |
16.09. | Immunovia AB: Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference | 343 | PR Newswire | LUND, Sweden, Sept. 16, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today presented detailed model-development study results at the... ► Artikel lesen | |
12.09. | IMMUNOVIA AB: Immunovia carries out a directed issue of units to guarantors in connection with the completed rights issue | 2 | Cision News | ||
03.09. | IMMUNOVIA AB: Immunovia announces final outcome in rights issue | 2 | Cision News | ||
02.09. | IMMUNOVIA AB: Immunovia publishes preliminary outcome in rights issue | 1 | Cision News | ||
13.08. | Nasdaq Stockholm AB: Listing of units rights and paid subscription units of Immunovia AB | 349 | GlobeNewswire | With effect from August 16, 2024, the unit rights of Immunovia AB will be
traded on the list for Equity rights. Trading will continue up until and
including August 27, 2024.
Instrument: Unit rights... ► Artikel lesen | |
12.08. | IMMUNOVIA AB: Immunovia publishes prospectus in connection with forthcoming rights issue | 1 | Cision News | ||
12.08. | XFRA CAPITAL ADJUSTMENT INFORMATION - 12.08.2024 | 409 | Xetra Newsboard | Das Instrument 1YR SE0006091997 IMMUNOVIA AB EQUITY wird cum Kapitalmassnahme gehandelt am 12.08.2024 und ex Kapitalmassnahme am 13.08.2024 The instrument 1YR SE0006091997 IMMUNOVIA AB EQUITY is traded... ► Artikel lesen | |
06.08. | IMMUNOVIA AB: Immunovia announces final terms of rights issue | 4 | Cision News | ||
05.08. | Immunovia AB: Immunovia Publishes Interim Report for January-June 2024 | 880 | PR Newswire | LUND, Sweden, Aug. 5, 2024 /PRNewswire/ --
April-June 2024
Net sales, consisting of royalties, amounted to 85 KSEK (412)Net earnings amounted to -25.6 MSEK (-185.1), where one-off... ► Artikel lesen | |
05.08. | Immunovia AB: Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health | 108 | PR Newswire | LUND, Sweden, Aug. 5, 2024 /PRNewswire/ -- Immunovia (STO: IMMNOV), the pancreatic cancer diagnostics company, today announces that the company's next-generation test to detect pancreatic... ► Artikel lesen | |
02.08. | Immunovia AB: Immunovia files US patent application to protect its next-generation test | 195 | PR Newswire | LUND, Sweden, Aug. 2, 2024 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the pancreatic cancer diagnostics company, today announces the company has filed a US provisional patent application... ► Artikel lesen | |
01.08. | Immunovia AB: Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy | 414 | PR Newswire | LUND, Sweden, Aug. 1, 2024 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the pancreatic cancer diagnostics company, today announces enhanced performance for its next-generation test... ► Artikel lesen | |
29.07. | Immunovia AB: Invitation to Immunovia's Q2 presentation | 221 | PR Newswire | LUND, Sweden, July 29, 2024 /PRNewswire/ -- Immunovia will publish its second quarter 2024 results on August 5, 2024 at 8:30 am CET. Analysts, investors and media are invited to a webcast... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TELADOC HEALTH | 9,251 | +8,26 % | If You'd Invested $10,000 in Teladoc Stock 5 Years Ago, Here's How Much You'd Have Today | ||
BECTON DICKINSON | 211,00 | 0,00 % | Minimaler Kursabschlag bei der Becton Dickinson-Aktie (212,2706 €) | Wenig Kursbewegung zur Stunde bei der Aktie von Becton Dickinson . Das Papier notiert derzeit bei 224,82 US-Dollar. Der heutige Börsentag brachte bislang wenig Kursbewegung bei der Becton Dickinson-Aktie.... ► Artikel lesen | |
HIMS & HERS HEALTH | 22,000 | +6,38 % | Starke Konkurrenz befürchtet: Hims & Hers: Katastrophaler Crash nach Allzeithoch! | © Foto: UnsplashDie Anteile der Online-Apotheke Hims & Hers stehen unter Druck, nachdem E-Commerce-Riese Amazon angekündigt hat, einen Telemedizin-Service zu starten.Hinter der Aktie der US-Online-Apotheke... ► Artikel lesen | |
DEXCOM | 70,62 | -1,08 % | Aktienmarkt: Starke Nachfrage treibt Kurs der Aktie von Dexcom (71,3101 €) | Im US-amerikanischen Wertpapierhandel brilliert zur Stunde der Anteilsschein von Dexcom . Das Wertpapier verteuert sich heute deutlich. Zu den auffälligsten Werten am US-amerikanischen Aktienmarkt gehört... ► Artikel lesen | |
INVITAE | 0,110 | 0,00 % | Ex-Invitae Spinoff Relaunches as Citizen Health, Picks Up $14.5M in Seed Funding | ||
ATOSSA THERAPEUTICS | 1,158 | +2,12 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Five Abstracts Highlighting (Z)-Endoxifen Research Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium | SEATTLE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical stage biopharmaceutical company developing innovative medicines in areas... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,520 | 0,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn-based Wound Care Hydrogel | BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
RYMAN HEALTHCARE | 2,720 | +2,95 % | RYMAN HEALTHCARE LIMITED: SPH Notice - Forsyth Barr Investment Management Limited | ||
CYTOSORBENTS | 0,877 | +0,46 % | CytoSorbents; Converge Biotech: CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India | PRINCETON, N.J. and HYDERABAD, India, Nov. 11, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 0,839 | -1,18 % | TPST Stock Plummets to 52-Week Low at $0.85 Amid Market Struggles | ||
ONTRAK | 1,883 | 0,00 % | OTRK-Aktie erreicht 52-Wochen-Tief bei 1,70 US-Dollar | ||
PATTERSON COMPANIES | 19,900 | +4,74 % | Patterson Companies Stock Up Following Latest Partnership Extension | ||
STAAR SURGICAL | 24,960 | -0,12 % | STAAR Surgical (NASDAQ:STAA) Reaches New 1-Year Low - Here's Why | ||
SENSEONICS | 0,299 | -1,64 % | Senseonics Holdings, Inc. - 8-K, Current Report |